Impact of amyloid-PET in daily clinical management of patients with cognitive impairment fulfilling appropriate use criteria

To evaluate the use of amyloid-positron emission tomography (PET) in routine clinical practice, in a selected population with cognitive impairment that meets appropriate use criteria (AUC). A multicenter, observational, prospective case-series study of 211patients from 2 level-3 hospitals who fulfil...

Descripción completa

Detalles Bibliográficos
Autores principales: Triviño-Ibáñez, Eva María, Sánchez-Vañó, Raquel, Sopena-Novales, Pablo, Romero-Fábrega, Juan Carlos, Rodríguez-Fernández, Antonio, Carnero Pardo, Cristóbal, Martínez Lozano, María Dolores, Gómez-Río, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708756/
https://www.ncbi.nlm.nih.gov/pubmed/31335725
http://dx.doi.org/10.1097/MD.0000000000016509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708756/
https://www.ncbi.nlm.nih.gov/pubmed/31335725
http://dx.doi.org/10.1097/MD.0000000000016509

Ejemplares similares